Dublin, June 25, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/43...eterinary_ ) has announced the addition of the "Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020" report to their offering. The global animal vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020. In this report, the global animal vaccines market is segmented on the basis of products, diseases, technologies, and regions. Based on product type, the veterinary vaccine market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines (including vaccines for deer, elephants, camels, bats, and rabbits). Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans, and the growing pet population. On the basis of diseases, the animal vaccines market is classified into companion animal diseases, poultry diseases, porcine diseases, equine diseases, and aquaculture diseases. The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment accounted for the highest growth veterinary vaccine technologies market in 2014. Growth of the veterinary vaccines market is propelled by growing prevalence of animal diseases; rising incidences of zoonotic diseases in humans; increasing investments by various government agencies, animal associations, and leading players; continuous innovations and introduction of new veterinary vaccines. Furthermore, technological innovations like DNA vaccines, growing awareness of animal health in emerging economies, increasing investment opportunities in emerging and immature markets are also the factors driving the market growth. However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market. Key players operating in the veterinary vaccines market are Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Ceva (France), Elcano Animal Health (USA), Heska Co. (U.S.), Merck Animal Health (U.S.), Merial (Sanofi) (U.S.), Virbac (France), and Zoetis (Pfizer) (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Veterinary Vaccines Market, By Product 7 Veterinary Vaccines Market, By Disease 8 Veterinary Vaccines Market, By Technology 9 Veterinary Vaccines Market, By Region 10 Competitive Landscape 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/43...eterinary_
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals, Animal Healthcare/Veterinary
